Luna Innovations Inc (LUNA) Inventory Turnover Ratio, from third quarter 2023 to third quarter 2022, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Luna Innovations Inc  (NASDAQ: LUNA)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Luna Innovations Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2023, Luna Innovations Inc's inventory turnover ratio sequentially decreased to 1.17 in the third quarter 2023, unsurprisingly, as the Luna Innovations Inc markets continue to deteriorate, and LUNA's faces growing challenges to bring down its inventories. Luna Innovations Inc's average inventory processing period in the Sep 30 2023 quarter, has increased to 312 days, from 294 days, in the Jun 30 2023 quarter.

Within Healthcare sector 329 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1488 in the second quarter 2023, to 1537.

LUNA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Luna Innovations Inc Market Share?

What is Inventory Turnover Ratio?




LUNA Inventory Turnover Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Inventory Growth 33.7 % 36.58 % 37.33 % 62.64 % 27.81 %
Y / Y Cost of Sales Growth 6.26 % 17.66 % 22.8 % 22.4 % 57.96 %
Inventory Turnover Ratio (TTM) 1.17 1.24 1.29 1.34 1.42
LUNA's Total Ranking # 1537 # 1488 # 1556 # 1852 #
Average inventory processing period 311 295 284 273 257
Seq. Inventory Growth 3.13 % 5.87 % 8.45 % 12.91 % 5.35 %
Seq. Cost of Sales Growth 8.33 % 19.14 % -18.54 % 1.07 % 19.95 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 17
Healthcare Sector # 330
Overall Market # 1537

Inventory Turnover Ratio Statistics
High Average Low
5.94 3.41 1.17
(Dec 31 2012)   (Sep 30 2023)




Financial Statements
Luna Innovations Inc's Inventories $ 43 Millions Visit LUNA's Balance sheet
Luna Innovations Inc's Cost of Revenues TTM $ 47 Millions Visit LUNA's Income Statement
What are LUNA's Sales? Visit LUNA's Sales by Segment

Other Inventory Turnover Ratios
Luna Innovations Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Laboratories Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
LUNA's Inventory Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for LUNA's Competitors
Inventory Turnover Ratio for LUNA's Suppliers
Inventory Turnover Ratio for LUNA's Customers

You may also want to know
LUNA's Sales Growth Rates LUNA's Pe Price to earnings ratio LUNA's Receivables Turnover Ratio LUNA's Stock Quote
LUNA's Net Income Growth Rates LUNA's Ps Price to Sales ratio LUNA's Sales per Employee LUNA's Asset Turnover Ratio
LUNA's Net Margin LUNA's Pb Price to Book ratio LUNA's Financial Strength Ratios LUNA's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2023 Inventories at quarter ending Sep 30 2023
Somalogic Inc   3.01 $ 43.557  Millions$ 14  Millions
Quidelortho Corp  2.90 $ 1,557.599  Millions$ 537  Millions
Aytu Biopharma Inc  2.90 $ 37.377  Millions$ 13  Millions
Mettler toledo International Inc   2.90 $ 1,188.193  Millions$ 410  Millions
Avid Bioservices Inc   2.89 $ 121.815  Millions$ 42  Millions
Illumina Inc   2.89 $ 1,722.000  Millions$ 597  Millions
Elutia Inc   2.86 $ 26.390  Millions$ 9  Millions
Dentsply Sirona Inc   2.86 $ 1,855.000  Millions$ 649  Millions
Telesis Bio Inc   2.86 $ 9.023  Millions$ 3  Millions
Tandem Diabetes Care Inc   2.86 $ 381.324  Millions$ 133  Millions
Angiodynamics Inc   2.83 $ 162.768  Millions$ 58  Millions
Amneal Pharmaceuticals Inc   2.81 $ 1,533.561  Millions$ 547  Millions
Evolus Inc   2.79 $ 55.659  Millions$ 20  Millions
Pfizer Inc  2.77 $ 27,041.000  Millions$ 9,759  Millions
Iridex Corp  2.74 $ 29.531  Millions$ 11  Millions
Msa Safety Inc  2.74 $ 924.000  Millions$ 337  Millions
Waters Corporation  2.73 $ 1,225.053  Millions$ 448  Millions
Abbott Laboratories  2.73 $ 18,012.000  Millions$ 6,592  Millions
Merck and Co Inc   2.70 $ 16,095.000  Millions$ 5,959  Millions
Hologic Inc  2.69 $ 1,788.500  Millions$ 666  Millions
Electromedical Technologies Inc   2.68 $ 0.313  Millions$ 0  Millions
Skinhealth Systems Inc   2.67 $ 280.806  Millions$ 105  Millions
Zynex inc   2.67 $ 37.482  Millions$ 14  Millions
Axsome Therapeutics Inc   2.66 $ 20.978  Millions$ 8  Millions
Quanterix Corporation  2.66 $ 48.002  Millions$ 18  Millions
Logicmark Inc  2.62 $ 3.271  Millions$ 1  Millions
International Stem Cell Corporation  2.61 $ 3.454  Millions$ 1  Millions
Amphastar Pharmaceuticals Inc   2.61 $ 275.164  Millions$ 105  Millions
Perrigo Company Plc  2.60 $ 3,018.000  Millions$ 1,163  Millions
Lifevantage Corp  2.58 $ 43.058  Millions$ 17  Millions

Date modified: 2026-09-08T15:11:07+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.